These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10494289)

  • 21. Recent developments in the management of bladder cancer: Introduction.
    Smith AB
    Urol Oncol; 2018 Mar; 36(3):95-96. PubMed ID: 29158137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological changes due to intravesical instillation of mitomycin C.
    Castillo OA; Landerer E; Feria-Flores M; Vidal-Mora I; Franco C
    Arch Esp Urol; 2012 Jun; 65(5):578-82; discussion 582. PubMed ID: 22732786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Future therapies for the treatment of bladder neoplasms.
    See WA; Berman CJ
    Semin Surg Oncol; 1997; 13(5):376-88. PubMed ID: 9259094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sarcomatoid variant of urothelial carcinoma of the urinary bladder.
    Bansal A; Kumar N; Sharma SC
    J Cancer Res Ther; 2013; 9(4):571-3. PubMed ID: 24518698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer.
    Tree AC; Jones K; Hafeez S; Sharabiani MTA; Harrington KJ; Lalondrelle S; Ahmed M; Huddart RA
    Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1168-1171. PubMed ID: 30012528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correspondence re: W. Paile's letter to the editor. Cancer Res., 60: 1146, 2000.
    Romanenko A; Vozianov A; Morimura K; Fukushima S
    Cancer Res; 2001 Sep; 61(18):6964-5. PubMed ID: 11559577
    [No Abstract]   [Full Text] [Related]  

  • 27. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
    Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
    Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rebuttal from author re: Axel Heidenreich. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ preserving therapy in carefully selected patients. Eur Urol 2008;54:21-23.
    Herr HW
    Eur Urol; 2008 Jul; 54(1):23-4. PubMed ID: 18262335
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness of the combination of vascular targeted photodynamic therapy and anti-cytotoxic T-lymphocyte-associated antigen 4 in a preclinical mouse model of urothelial carcinoma.
    Corradi RB; LaRosa S; Jebiwott S; Murray KS; Rosenzweig B; Somma AJ; Gomez RS; Scherz A; Kim K; Coleman JA
    Int J Urol; 2019 Mar; 26(3):414-422. PubMed ID: 30659668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combined treatment of bladder radiation injuries].
    Zadërin VP; Polianichko MF
    Vopr Onkol; 1982; 28(3):73-7. PubMed ID: 7064423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation Induced Cystitis and Proctitis - Prediction, Assessment and Management.
    Mallick S; Madan R; Julka PK; Rath GK
    Asian Pac J Cancer Prev; 2015; 16(14):5589-94. PubMed ID: 26320421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent developments in the treatment of advanced bladder cancer.
    Godwin JL; Hoffman-Censits J; Plimack E
    Urol Oncol; 2018 Mar; 36(3):109-114. PubMed ID: 29395952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carcinoma in situ of the urinary bladder--definition and status of treatment].
    Otto T; Rübben H
    Urologe A; 1991 May; 30(3):163-6. PubMed ID: 1871934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation cystitis with pseudocarcinomatous urothelial hyperplasia.
    Humphrey PA
    J Urol; 2013 Dec; 190(6):2251-2. PubMed ID: 24045222
    [No Abstract]   [Full Text] [Related]  

  • 35. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ-preserving therapy in carefully selected patients.
    Heidenreich A
    Eur Urol; 2008 Jul; 54(1):21-3. PubMed ID: 18262722
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravesical therapy for bladder cancer.
    Williams SK; Hoenig DM; Ghavamian R; Soloway M
    Expert Opin Pharmacother; 2010 Apr; 11(6):947-58. PubMed ID: 20205607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radiogenic cystitis; endoscopic diagnosis, classification and therapy].
    Seppelt U; Buhl K
    Fortschr Med; 1978 Jan; 96(3):136-8. PubMed ID: 620968
    [No Abstract]   [Full Text] [Related]  

  • 39. New horizons for GAG therapy in the management of urothelial damage.
    Lazzeri M
    Urologia; 2015 Oct; 82 Suppl 3():S10-4. PubMed ID: 26496969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current therapy of bladder carcinoma.
    Grossman HB
    J Urol; 1979 Jan; 121(1):1-7. PubMed ID: 104055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.